Files in this item
Human immunodeficiency virus seroconversion presenting with acute inflammatory demyelinating polyneuropathy : a case report
Item metadata
dc.contributor.author | Sloan, Derek J | |
dc.contributor.author | Nicolson, Andrew | |
dc.contributor.author | Miller, Alastair RO | |
dc.contributor.author | Beeching, Nick J | |
dc.contributor.author | Beadsworth, Mike BJ | |
dc.date.accessioned | 2018-03-28T09:30:08Z | |
dc.date.available | 2018-03-28T09:30:08Z | |
dc.date.issued | 2008-12-04 | |
dc.identifier | 241962617 | |
dc.identifier | 02e6528a-495a-4827-a4d8-632d7841c1fa | |
dc.identifier | 59049103227 | |
dc.identifier.citation | Sloan , D J , Nicolson , A , Miller , A RO , Beeching , N J & Beadsworth , M BJ 2008 , ' Human immunodeficiency virus seroconversion presenting with acute inflammatory demyelinating polyneuropathy : a case report ' , Journal of Medical Case Reports , vol. 2 , 370 . https://doi.org/10.1186/1752-1947-2-370 | en |
dc.identifier.issn | 1752-1947 | |
dc.identifier.other | Bibtex: urn:e0d3174b17ad0efaec42a73d5b368495 | |
dc.identifier.other | ORCID: /0000-0002-7888-5449/work/60631037 | |
dc.identifier.uri | https://hdl.handle.net/10023/13038 | |
dc.description.abstract | Introduction: Acute Human Immunodeficiency Virus infection is associated with a range of neurological conditions. Guillain-Barré syndrome is a rare presentation; acute inflammatory demyelinating polyneuropathy is the commonest form of Guillain-Barré syndrome. Acute inflammatory demyelinating polyneuropathy has occasionally been reported in acute Immunodeficiency Virus infection but little data exists on frequency, management and outcome. Case presentation: We describe an episode of Guillain-Barré syndrome presenting as acute inflammatory demyelinating polyneuropathy in a 30-year-old man testing positive for Immunodeficiency Virus, probably during acute seroconversion. Clinical suspicion was confirmed by cerebrospinal fluid analysis and nerve conduction studies. Rapid clinical deterioration prompted intravenous immunoglobulin therapy and early commencement of highly active anti-retroviral therapy. All symptoms resolved within nine weeks. Conclusion: Unusual neurological presentations in previously fit patients are an appropriate indication for Immunodeficiency-Virus testing. Highly active anti-retroviral therapy with adequate penetration of the central nervous system should be considered as an early intervention, alongside conventional therapies such as intravenous immunoglobulin. | |
dc.format.extent | 5 | |
dc.format.extent | 393470 | |
dc.language.iso | eng | |
dc.relation.ispartof | Journal of Medical Case Reports | en |
dc.rights | © Sloan et al; licensee BioMed Central Ltd. 2008. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. | en |
dc.subject | Human immunodeficiency virus | en |
dc.subject | Efavirenz | en |
dc.subject | Human immunodeficiency virus testing | en |
dc.subject | Intravenous immunoglobulin therapy | en |
dc.subject | Acute inflammatory demyelinating polyneuropathy | en |
dc.subject | RA0421 Public health. Hygiene. Preventive Medicine | en |
dc.subject | RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject.lcc | RA0421 | en |
dc.subject.lcc | RC0321 | en |
dc.title | Human immunodeficiency virus seroconversion presenting with acute inflammatory demyelinating polyneuropathy : a case report | en |
dc.type | Journal article | en |
dc.contributor.institution | University of St Andrews.School of Medicine | en |
dc.identifier.doi | 10.1186/1752-1947-2-370 | |
dc.description.status | Peer reviewed | en |
This item appears in the following Collection(s)
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.